BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

317 related articles for article (PubMed ID: 17893759)

  • 21. High resistance to fourth-generation cephalosporins among clinical isolates of Enterobacteriaceae producing extended-spectrum beta-lactamases isolated in Portugal.
    Fernandes R; Gestoso A; Freitas JM; Santos P; Prudêncio C
    Int J Antimicrob Agents; 2009 Feb; 33(2):184-5. PubMed ID: 18926667
    [No Abstract]   [Full Text] [Related]  

  • 22. Orthodox and unorthodox clavulanate combinations against extended-spectrum beta-lactamase producers.
    Livermore DM; Hope R; Mushtaq S; Warner M
    Clin Microbiol Infect; 2008 Jan; 14 Suppl 1():189-93. PubMed ID: 18154546
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Breakpoints for intravenously used cephalosporins in Enterobacteriaceae--EUCAST and CLSI breakpoints.
    Kahlmeter G
    Clin Microbiol Infect; 2008 Jan; 14 Suppl 1():169-74. PubMed ID: 18154542
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Prevalence of colonisation with third-generation cephalosporin-resistant Enterobacteriaceae in ICU patients of Heidelberg University Hospitals.
    von Baum H; Lin D; Wendt C
    Clin Microbiol Infect; 2004 May; 10(5):436-40. PubMed ID: 15113322
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Multidrug resistance among Enterobacteriaceae is strongly associated with the presence of integrons and is independent of species or isolate origin.
    Leverstein-van Hall MA; M Blok HE; T Donders AR; Paauw A; Fluit AC; Verhoef J
    J Infect Dis; 2003 Jan; 187(2):251-9. PubMed ID: 12552449
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Trends in yearly prevalence of third-generation cephalosporin and fluoroquinolone resistant Enterobacteriaceae infections and antimicrobial use in Spanish hospitals, Spain, 1999 to 2010.
    Asensio A; Alvarez-Espejo T; Fernandez-Crehuet J; Ramos A; Vaque-Rafart J; Bishopberger C; Hernandez Navarrete M; Calbo-Torrecillas F; Campayo J; Canton R;
    Euro Surveill; 2011 Oct; 16(40):. PubMed ID: 21996380
    [No Abstract]   [Full Text] [Related]  

  • 27. Prevalence of multiresistant Gram-negative organisms in a surgical hospital in Ho Chi Minh City, Vietnam.
    Jones SL; Nguyen VK; Nguyen TM; Athan E
    Trop Med Int Health; 2006 Nov; 11(11):1725-30. PubMed ID: 17054753
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Prevalent phenotypes and antibiotic resistance in Escherichia coli and Klebsiella pneumoniae at an Indian tertiary care hospital: plasmid-mediated cefoxitin resistance.
    Shahid M; Malik A; Akram M; Agrawal LM; Khan AU; Agrawal M
    Int J Infect Dis; 2008 May; 12(3):256-64. PubMed ID: 17981482
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Prevalence of faecal carriage of Enterobacteriaceae with NDM-1 carbapenemase at military hospitals in Pakistan, and evaluation of two chromogenic media.
    Perry JD; Naqvi SH; Mirza IA; Alizai SA; Hussain A; Ghirardi S; Orenga S; Wilkinson K; Woodford N; Zhang J; Livermore DM; Abbasi SA; Raza MW
    J Antimicrob Chemother; 2011 Oct; 66(10):2288-94. PubMed ID: 21788293
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Comparison of disk diffusion, VITEK 2, and broth microdilution antimicrobial susceptibility test results for unusual species of Enterobacteriaceae.
    Stone ND; O'Hara CM; Williams PP; McGowan JE; Tenover FC
    J Clin Microbiol; 2007 Feb; 45(2):340-6. PubMed ID: 17135429
    [TBL] [Abstract][Full Text] [Related]  

  • 31. beta-Lactams without a suicide inhibitor.
    Giamarellou H
    Clin Microbiol Infect; 2008 Jan; 14 Suppl 1():194-7. PubMed ID: 18154547
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The ARESC study: an international survey on the antimicrobial resistance of pathogens involved in uncomplicated urinary tract infections.
    Schito GC; Naber KG; Botto H; Palou J; Mazzei T; Gualco L; Marchese A
    Int J Antimicrob Agents; 2009 Nov; 34(5):407-13. PubMed ID: 19505803
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Third-generation cephalosporins resistance in clinical isolates of Enterobacteriaceae.
    Perduca M; Pagani L; Cereda PM; Debiaggi M
    Microbiologica; 1986 Apr; 9(2):199-207. PubMed ID: 3487023
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Decontamination of cephalosporin-resistant Enterobacteriaceae during selective digestive tract decontamination in intensive care units.
    Oostdijk EA; de Smet AM; Kesecioglu J; Bonten MJ;
    J Antimicrob Chemother; 2012 Sep; 67(9):2250-3. PubMed ID: 22643189
    [TBL] [Abstract][Full Text] [Related]  

  • 35. High level cephalosporin-resistant Enterobacteriaceae ventilator-associated pneumonia: prognostic factors based on a cohort study.
    Aubron C; Chaari A; Bronchard R; Armand-Lefèvre L; Montravers P; Régnier B; Wolff M; Lucet JC
    J Hosp Infect; 2011 Jan; 77(1):64-9. PubMed ID: 21129817
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Effect of 1-(1-naphthylmethyl)-piperazine, a novel putative efflux pump inhibitor, on antimicrobial drug susceptibility in clinical isolates of Enterobacteriaceae other than Escherichia coli.
    Schumacher A; Steinke P; Bohnert JA; Akova M; Jonas D; Kern WV
    J Antimicrob Chemother; 2006 Feb; 57(2):344-8. PubMed ID: 16354746
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Community infections caused by extended-spectrum beta-lactamase-producing Escherichia coli.
    Rodríguez-Baño J; Alcalá JC; Cisneros JM; Grill F; Oliver A; Horcajada JP; Tórtola T; Mirelis B; Navarro G; Cuenca M; Esteve M; Peña C; Llanos AC; Cantón R; Pascual A
    Arch Intern Med; 2008 Sep; 168(17):1897-902. PubMed ID: 18809817
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Relationship between ceftriaxone use and resistance to third-generation cephalosporins among clinical strains of Enterobacter cloacae.
    Muller A; Lopez-Lozano JM; Bertrand X; Talon D
    J Antimicrob Chemother; 2004 Jul; 54(1):173-7. PubMed ID: 15150164
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Antimicrobial resistance profiles of community-acquired uropathogenic Escherichia coli isolates during 2004-2006 in a training hospital in Istanbul].
    Ozyurt M; Haznedaroğlu T; Sahiner F; Oncül O; Ceylan S; Ardiç N; Erdemoğlu A
    Mikrobiyol Bul; 2008 Apr; 42(2):231-43. PubMed ID: 18697421
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Role of beta-lactamase inhibitors in enterobacterial isolates producing extended-spectrum beta-lactamases.
    Bhattacharjee A; Sen MR; Prakash P; Anupurba S
    J Antimicrob Chemother; 2008 Feb; 61(2):309-14. PubMed ID: 18174199
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.